uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Factors influencing the choice of optimal individualized dosing strategies targeting a drug concentration or effect
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy.
2004 (English)In: AAPS PharmSci, ISSN 1522-1059Article in journal (Refereed) Submitted
Place, publisher, year, edition, pages
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-91734OAI: oai:DiVA.org:uu-91734DiVA: diva2:164563
Available from: 2004-04-26 Created: 2004-04-26 Last updated: 2011-10-07Bibliographically approved
In thesis
1. Estimation of Dosing Strategies for Individualisation
Open this publication in new window or tab >>Estimation of Dosing Strategies for Individualisation
2004 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

To increase the proportion of patients with successful drug treatment, dose individualisation on the basis of one or several patient characteristics, a priori individualisation, and/or on the basis of feedback observations from the patient following an initial dose, a posteriori individualisation, is an option. Efficient tools in optimising individualised dosing strategies are population models describing pharmacokinetics (PK) and the relation between pharmacokinetics and pharmacodynamics (PK/PD).

Methods for estimating optimal dosing strategies, with a discrete number of doses, for dose individualisation a priori and a posteriori were developed and explored using simulated data. The methods required definitions of (i) the therapeutic target, i.e. the value of the target variable and a risk function quantifying the seriousness of deviation from the target, (ii) a population PK/PD model relating dose input to the target variable in the patients to be treated, and (iii) distributions of relevant patient factors. Optimal dosing strategies, in terms of dose sizes and individualisation conditions, were estimated by minimising the overall risk. Factors influencing the optimal dosing strategies were identified. Consideration of those will have implications for study design, data collection, population model development and target definition.

A dosing strategy for a priori individualisation was estimated for NXY-059, a drug under development. Applying the estimated dosing strategy in a clinical study resulted in reasonable agreement between observed and expected outcome, supporting the developed methodology.

Estimation of a dosing strategy for a posteriori individualisation for oxybutynin, a drug marketed for the treatment of overactive bladder, illustrated the implementation of the method when defining the therapeutic target in terms of utility and responder probability, that is, as a combination of the desired and adverse effects.

The proposed approach provides an estimate of the maximal benefit expected from individualisation and, if individualisation is considered clinically superior, the optimal conditions for individualisation. The main application for the methods is in drug development where the methods can be generally employed in the establishment of dosing strategies for individualisation with relevant extensions regarding population model complexity and individualisation conditions.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2004. 62 p.
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 0282-7484 ; 312
Pharmaceutical biosciences, Dosing strategy, Individualisation, Pharmacokinetic, Pharmacodynamic, Modeling, NONMEM, Decision making, Farmaceutisk biovetenskap
National Category
Pharmaceutical Sciences
urn:nbn:se:uu:diva-4255 (URN)91-554-5960-9 (ISBN)
Public defence
2004-05-19, Room B21, BMC, Husargatan 3, Uppsala, 09:15
Available from: 2004-04-26 Created: 2004-04-26Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Karlsson, Mats O.
By organisation
Division of Pharmacokinetics and Drug Therapy
In the same journal
AAPS PharmSci
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 156 hits
ReferencesLink to record
Permanent link

Direct link